A team of researchers has found a way to steer the output of large language models by manipulating specific concepts inside ...

A marriage of formal methods and LLMs seeks to harness the strengths of both.

This year has seen some amazing advancements in fundamental mathematics. Researchers have made breakthroughs in geometry, topology, chaos theory, and more. And a startling three of our top 10 ...

Recursion Pharmaceuticals (RXRX) added ~11% in the morning trading on Wednesday after J.P. Morgan upgraded the AI-driven biotech to Overweight from Neutral, citing a blockbuster sales potential for ...

Recursion Pharmaceuticals Inc (NASDAQ: RXRX) shares moved higher Wednesday after JPMorgan upgraded the stock to Overweight from Neutral and lifted its price target to $11 from $10. What Happened: ...

Dec 8 (Reuters) - Recursion Pharma (RXRX.O), opens new tab, which uses artificial intelligence to discover new drug candidates, said on Monday its experimental oral drug helped reduce abnormal growths ...

Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at drewqjoseph.71. LONDON — In the year-plus since Najat Khan joined the AI-focused drug ...

For the past several years, America has been using its young people as lab rats in a sweeping, if not exactly thought-out, education experiment. Schools across the country have been lowering standards ...

After a challenging 12 years trying to use AI to create new medicines, cofounder Chris Gibson stepped down as CEO last week. Can R&D chief and new CEO Najat Khan turn it around? In 2014, Recursion ...

1 Partial Order and Hasse Diagram https://github.com/virtual-labs/exp-hasse-diagram-iiith v1.0.0 2 Equivalence Relation https://github.com/virtual-labs/exp ...

It's highly recommended to recruit Aza before completing this quest. Aza's companion quest requires you to clear out the N-Ray Range anyway, so you can kill two birds with one stone. Acquire the N-Ray ...

After 12 years leading Utah-based techbio company Recursion, CEO Chris Gibson is stepping down. Recursion’s R&D head and Chief Commercial Officer Najat Khan will become CEO effective Jan. 1. Gibson co ...